Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2568926rdf:typepubmed:Citationlld:pubmed
pubmed-article:2568926lifeskim:mentionsumls-concept:C0032019lld:lifeskim
pubmed-article:2568926lifeskim:mentionsumls-concept:C0033684lld:lifeskim
pubmed-article:2568926lifeskim:mentionsumls-concept:C0431085lld:lifeskim
pubmed-article:2568926lifeskim:mentionsumls-concept:C0074830lld:lifeskim
pubmed-article:2568926lifeskim:mentionsumls-concept:C1521991lld:lifeskim
pubmed-article:2568926lifeskim:mentionsumls-concept:C0439064lld:lifeskim
pubmed-article:2568926lifeskim:mentionsumls-concept:C1510827lld:lifeskim
pubmed-article:2568926lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:2568926lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:2568926pubmed:issue2lld:pubmed
pubmed-article:2568926pubmed:dateCreated1989-8-29lld:pubmed
pubmed-article:2568926pubmed:abstractTextPrevious studies have shown that somatostatin receptors on AtT-20 and GH3 pituitary tumor cells show relative preference for binding somatostatin-28 (S-28) and somatostatin-14 (S-14), respectively. Here we have attempted to determine whether this selectivity can be explained by molecular heterogeneity of the receptor. Cells were incubated with [125I-Tyr11]S-14, [125I-Leu8-D-Trp22,Tyr25]S-28, and [125I-Tyr3]SMS, and the bound ligand was chemically cross-linked with bis-[2-succinimido-oxycarbonyloxy)ethyl]sulfone, disuccinimidyl suberate, or dithiobis (succinimidyl propionate). The solubilized cross-linked material was analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, followed by autoradiography. [125I-Tyr11]S-14 labeled three specific receptor proteins of 57K, 42K, and 27K mol wt in AtT-20 cells. The relative proportions of the protein bands were unaltered by the use of whole cells or cell membranes or by the inclusion of dithiothreitol or antiproteolytic agents. With both [125I-Tyr11]S-14 and [125I-LTT]S-28, the 57K protein constituted the major labeled component, representing 70-75% of the total cross-linked proteins. Labeling of the three protein species by [125I-Tyr11]S-14 and [125I-LTT]S-28 was inhibited by both S-14 and S-28 in a dose-dependent manner. S-28 was 10-20 times more potent than S-14 for inhibiting the labeling by both ligands of the principal receptor species of 57K. By contrast, when a radioiodinated derivative of the octapeptide analog octreotide ([125I-Tyr3]SMS) was used as ligand, the 27K protein was preferentially labeled, whereas the 57K and 42K bands were detected only as minor components. Labeling of GH3 cells with [125I-Tyr11]S-14 and [125I-LTT]S-28 revealed three cross-linked proteins of 57K, 42K, and 27K mol wt similar to those observed in AtT-20 cells. However, in this cell line the 27K protein, not the 57K species, was the dominant component identified with these two ligands, comprising 40-50% of the total cross-linked proteins. These results suggest that there are three somatostatin receptor proteins of 57K, 42K, and 27K in pituitary cells. In AtT-20 cells, the 57K protein constitutes the major receptor protein labeled by [125I-Tyr11]S-14 and [125I-LTT]S-28, whereas the 27K protein is the major species labeled by [125I-Tyr3]SMS. The 27K, not the 57K, moiety is the principal receptor form in GH3 cells. Such ligand- and tissue-selective binding by the somatostatin receptor provides strong evidence for receptor molecular heterogeneity.lld:pubmed
pubmed-article:2568926pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2568926pubmed:languageenglld:pubmed
pubmed-article:2568926pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2568926pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2568926pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2568926pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2568926pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2568926pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2568926pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2568926pubmed:statusMEDLINElld:pubmed
pubmed-article:2568926pubmed:monthAuglld:pubmed
pubmed-article:2568926pubmed:issn0013-7227lld:pubmed
pubmed-article:2568926pubmed:authorpubmed-author:PatelY CYClld:pubmed
pubmed-article:2568926pubmed:authorpubmed-author:MurthyK KKKlld:pubmed
pubmed-article:2568926pubmed:authorpubmed-author:SrikantC BCBlld:pubmed
pubmed-article:2568926pubmed:issnTypePrintlld:pubmed
pubmed-article:2568926pubmed:volume125lld:pubmed
pubmed-article:2568926pubmed:ownerNLMlld:pubmed
pubmed-article:2568926pubmed:authorsCompleteYlld:pubmed
pubmed-article:2568926pubmed:pagination948-56lld:pubmed
pubmed-article:2568926pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:2568926pubmed:meshHeadingpubmed-meshheading:2568926-...lld:pubmed
pubmed-article:2568926pubmed:meshHeadingpubmed-meshheading:2568926-...lld:pubmed
pubmed-article:2568926pubmed:meshHeadingpubmed-meshheading:2568926-...lld:pubmed
pubmed-article:2568926pubmed:meshHeadingpubmed-meshheading:2568926-...lld:pubmed
pubmed-article:2568926pubmed:meshHeadingpubmed-meshheading:2568926-...lld:pubmed
pubmed-article:2568926pubmed:meshHeadingpubmed-meshheading:2568926-...lld:pubmed
pubmed-article:2568926pubmed:meshHeadingpubmed-meshheading:2568926-...lld:pubmed
pubmed-article:2568926pubmed:meshHeadingpubmed-meshheading:2568926-...lld:pubmed
pubmed-article:2568926pubmed:meshHeadingpubmed-meshheading:2568926-...lld:pubmed
pubmed-article:2568926pubmed:meshHeadingpubmed-meshheading:2568926-...lld:pubmed
pubmed-article:2568926pubmed:meshHeadingpubmed-meshheading:2568926-...lld:pubmed
pubmed-article:2568926pubmed:year1989lld:pubmed
pubmed-article:2568926pubmed:articleTitleEvidence for multiple protein constituents of the somatostatin receptor in pituitary tumor cells: affinity cross-linking and molecular characterization.lld:pubmed
pubmed-article:2568926pubmed:affiliationFraser Laboratories Department of Medicine, McGill University, Royal Victoria Hospital, Montreal, Quebec, Canada.lld:pubmed
pubmed-article:2568926pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2568926pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2568926pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2568926lld:pubmed